MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Pfizer

Gesloten

SectorGezondheidszorg

24.72 0.82

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

24.31

Max

24.72

Belangrijke statistieken

By Trading Economics

Inkomsten

-4.1B

411M

Verkoop

63M

18B

K/W

Sectorgemiddelde

17.972

63.778

EPS

0.63

Dividendrendement

6.79

Winstmarge

2.314

Werknemers

81,000

EBITDA

-4.3B

2.5B

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+24.61% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

6.79%

2.39%

Volgende Winsten

29 apr 2025

Volgende dividenddatum

13 jun 2025

Volgende Ex Dividend datum

8 mei 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-7.5B

144B

Vorige openingsprijs

23.9

Vorige sluitingsprijs

24.72

Nieuwssentiment

By Acuity

45%

55%

165 / 386 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bearish Evidence

Pfizer Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

19 mrt 2025, 07:34 UTC

Acquisities, Fusies, Overnames

Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion

18 mrt 2025, 17:26 UTC

Acquisities, Fusies, Overnames

Pfizer to Dispose of Remaining Shareholding in Haleon

4 feb 2025, 18:52 UTC

Belangrijke Marktbewegers

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

4 feb 2025, 14:58 UTC

Winsten
Belangrijke Marktbewegers

Pfizer Shares Rise on Better-Than-Expected 4Q

26 mrt 2025, 22:29 UTC

Top Nieuws

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- 2nd Update

26 mrt 2025, 19:19 UTC

Top Nieuws

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- Update

26 mrt 2025, 17:39 UTC

Top Nieuws

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- WSJ

18 mrt 2025, 16:58 UTC

Acquisities, Fusies, Overnames

Haleon Intends to Cancel Purchased Ordinary Shares

18 mrt 2025, 16:57 UTC

Acquisities, Fusies, Overnames

Citigroup: Off-Market Transaction Will Close at Same Time as or Following Settlement of Offering

18 mrt 2025, 16:56 UTC

Acquisities, Fusies, Overnames

Citigroup: Off-Market Purchase Worth Approx GBP170M in Ordinary Shares

18 mrt 2025, 16:56 UTC

Acquisities, Fusies, Overnames

Citigroup: Haleon Agreed to Carry out Off-Market Purchase From Pfizer

18 mrt 2025, 16:52 UTC

Acquisities, Fusies, Overnames

Haleon Takes Note of Announcement

18 mrt 2025, 16:50 UTC

Acquisities, Fusies, Overnames

Citigroup: Haleon Won't Receive Any Net Proceeds From Offering

18 mrt 2025, 16:50 UTC

Acquisities, Fusies, Overnames

Citigroup: This Is Subject to Customary Closing Conditions

18 mrt 2025, 16:50 UTC

Acquisities, Fusies, Overnames

Citigroup: Pfizer Will Receive All of Net Proceeds From Offering

18 mrt 2025, 16:49 UTC

Acquisities, Fusies, Overnames

Citigroup: Bookbuilding Period May Close at Any Time on Short Notice

18 mrt 2025, 16:49 UTC

Acquisities, Fusies, Overnames

Citigroup: Bookbuilding Period Will Commence Immediately

18 mrt 2025, 16:49 UTC

Acquisities, Fusies, Overnames

Citigroup: Price Per Sale Share to Be Determined Through Accelerated Bookbuilding Process

18 mrt 2025, 16:48 UTC

Acquisities, Fusies, Overnames

Citigroup: Pfizer Intends to Sell Ordinary Shares to Institutional Investors

18 mrt 2025, 16:47 UTC

Acquisities, Fusies, Overnames

Citigroup:: Amount Is Pfizer's Entire Residual Shareholding in Haleon

18 mrt 2025, 16:47 UTC

Acquisities, Fusies, Overnames

Citigroup: This Represents Approx 7.3% Stake in Haleon

18 mrt 2025, 16:46 UTC

Acquisities, Fusies, Overnames

Citigroup: Pfizer Intends to Sell Approx 662M Ordinary Shares in Haleon

17 mrt 2025, 09:00 UTC

Top Nieuws

Pfizer Has a New Playbook for Reviving Sales -- And It's Starting to Pay Off -- WSJ

28 feb 2025, 12:00 UTC

Top Nieuws

Drug Stocks Are the New Safe Bet in a Shaky Market -- Heard on the Street -- WSJ

14 feb 2025, 11:38 UTC

Top Nieuws
Winsten

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

14 feb 2025, 11:30 UTC

Top Nieuws
Winsten

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

5 feb 2025, 12:00 UTC

Top Nieuws

Merck Is Suffering From a Classic Pharma Problem -- Heard on the Street -- WSJ

4 feb 2025, 19:34 UTC

Top Nieuws

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 3rd Update

4 feb 2025, 19:10 UTC

Top Nieuws

Pfizer Falls on RFK's Progress Towards Confirmation Despite Good Earnings. Its CEO is Unbothered. -- Barrons.com

4 feb 2025, 18:51 UTC

Top Nieuws

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 2nd Update

Peer Vergelijking

Prijswijziging

Pfizer Prognose

Koersdoel

By TipRanks

24.61% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 30.58 USD  24.61%

Hoogste 36 USD

Laagste 27 USD

Gebaseerd op 15 Wall Street-analisten die 12-maands prijsdoelen bieden voor Pfizer - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

15 ratings

6

Buy

9

Hold

0

Sell

Technische score

By Trading Central

N/A / 25.23Steun & Weerstand

Korte Termijn

Bearish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

165 / 386 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.